1Otani A, Kinder K, Ewalt K, et al. Bone marrow-derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis[J]. Nat Med,2002,8(9) :1004-1010.
2Espinosa-Heidmann DG, Caicedo A, Hernandez EP, et al. Cousinsl bone marrow-derived progenitor cells contribute to experimental choroidal neovascularization [J]. Invest Ophthalmol Vis Sci, 2003, 44 (11) :4914-4919.
3Grossniklaus HE, Green WR. Histopathologic and ultrastructural findings of surgically excised choroidal neovascularization[J]. Submacular Surgery Trials Research Group Arch Ophthalmol, 1998,116 (6) :745-749.
4Hammes HP, Hoerauf H, Alt A, et al. Ne(carboxymethyl)lysin and the AGE receptor RAGE coloealize in age-related macular degeneration[J]. Invest Ophthalmol Vis Sei,1999,40(8):1855-1859.
5Knott RM, Robertson M, Muckersie E, et al. A model system for the study of human retinal angiogenesis., aetivation of monocytes and endothelial eells and the assoeiation with the expression of the monocarboxylate transporter type 1 (MCT-1) [J]. Diabetologia, 1999,42 (7) :870-877.
6Sakurai E, Anand A, Ambati BK, et al. Macrophage depletion inhibits experimental ehoroidal neovascularization[J]. Invest Ophthaltool Vis Sci,2003,44(8):3578-3585.
7HoltkampGM, DeVosAF, PeekR, et al. Analysis of the secretion pattern of monocyte chemotactic protein-1 (MCP-1) and transfor ming growth factor-beta 2 (TGF-β2) by human retinal pigment epithelial eells[J]. Clin Exp Immunol, 1999,118(1) :35-40.
8Oh H, Takagi H, Takagi C, et al. The potential angiogenie role of maerophages in the formation of ehoroidal neovaseular membranes [J]. Invest Ophthalmol Vis Sei,1999,40(9) : 1891-1898.
9Ishibashi T, Hata Y, Yoshikawa H, et al. Expression of vascular endothelial growth factor in experimental choroidal neovascularization[J]. Graefes Arch Clin Exp Ophthalmol, 1997,235 (3): 159-167.
10Yi X, Ogata N, Komada M, et al. Vascular endothelial growth factor expression in choroidal neovascuarizaion in rats[J]. Graefes Arch Exp Ophthalmol,1997,235(5):313-319.
2Grossniklaus HE, Green WR. Choroidal neovascularization. Am J Ophthalmol, 2004,137:496-503.
3Espinosa-Heidmann DG, Reinoso MA, Pina Y, et al. Quantitative enumeration of vascular smooth muscle cells and endothelial cells derived from bone marrow precursors in experimental choroidal neovascularization. Exp Eye Res, 2005,80:369-378.
4Espinosa-Heidmann DG, Caicedo A, Hemandez EP, et al. Bone marrow-derived progenitor cells contribute to experimental choroidal neovascularization. Invest Ophthalmol Vis Sci, 2003, 44:4914-4919.
5Espinosa-Heidmann DG, Suner I, Hemandez EP, et al. Age as an independent risk factor for severity of experimental choroidal neovascularization. Invest Ophthalmol Vis Sci, 2002,43 : 1567- 1573.
6Baffi JZ, Bymes GA, Wolfe JD, et al. Adult hematopoetic stem cells provide functional hemangioblast activity during choroidal neovascularization in mice. Invest Ophthalmol Vis Sci, 2003,44:1825.
7Tomita M, Yamada H, Adachi Y, et al. Choroidal neovascularization is provided by bone marrow cells. Stem Cells,2004,22:21-26.
8Sata M. Circulating progenitors contribute to angiogenesis, vascular repair, and lesion formation. Rinsho Byori, 2005,53:70- 76.
9Carmeliet P. Angiogenesis in life, disease and medicine. Nature, 2005,438:932-936.
10Ferrara N, Kerbel RS. Angiogenesis as a therapeutic target. Nature, 2005,438:967-974.
